Stoke Therapeutics, Inc. (STOK) stock forecast — our track record

Lyra published 20 STOK stock forecasts beginning September 29, 2025. Every prediction used the short term horizon (0 to 3 months). Each forecast was published before its outcome was known. All 20 calls are now closed and scored, with the final evaluation window ending May 7, 2026. This gives a consistent view of how the published short term calls performed over the period.

Overall, 12 forecasts reached their targets. Another 8 received partial credit, and none of them missed. The average success score was 76.3%. Because every call used the same horizon, the short term average was also 76.3%. The results included both forecasts that fully reached or exceeded their predicted growth and forecasts where the stock rose but stopped below the published target.

The best call was published October 1, 2025. It predicted 40% growth, and the stock rose as much as 64.9%. The target was reached in 13 days, and the call received a 100% success score. The worst call was published October 27, 2025. It predicted 35% growth, while the stock rose as much as 12.8%. It did not reach the target and received a 50% success score. The track record was positive overall: most targets were reached, no call was scored as a miss, and the weaker calls received partial credit rather than full success.